Sensitivity to antibacterials of Staphylococcus aureus isolated from skin infections: A comparison of two hospitals

Journal of International Medical Research

Volumn 25, Issue 1, 1997, Pages 8-13

  Nishijima, S ^a,d   Namura, S ^a   Nakagawa, M ^a   Kurokawa, I ^b   Kawabata, S ^c  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Tsukaguchi Prefectural Hospital   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antibacterial drugs; Hospital type; Skin infections; Staphylococcus aureus

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFACLOR; CEFPODOXIME PROXETIL; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; GREPAFLOXACIN; METICILLIN; MINOCYCLINE; NADIFLOXACIN; OFLOXACIN; TOSUFLOXACIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

EID: 0031036485     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059702500102     Document Type: Article

References (8)

1. Nishijima S, Namura S, Mitsuya K, et al: Retrospective study of bacteria isolated from skin infections during the past 15 years (1977 - 1991) at Kansai Medical University. Jpn J Dermatol 1993; 103: 1988-1991.
2. Nishijima S, Namura S, Nakagawa M, et al: Sensitivity to antibacterials of Staphylococcus aureus isolated from different types of skin infections. J Int Med Res 1997; 25: 1-7.
3. Kurokawa I, Akamatsu H, Nishijima S, et al: Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base. J Am Acad Dermatol 1991; 25: 674-691.
4. Imada T, Miyazaki S, Nisida M, et al: In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116. Antimicrob Agents Chemother 1992; 36: 573-579.
5. Wakebe H, Imada T, Yoneda H, et al: Evaluation of OPC-177116 against important pathogens that cause respiratory tract infections. Antimicrob Agents Chemother 1994; 38: 2340-2345.
6. Nakanishi N, Yoshida S, Wakebe H, et al: Mechanisms of clinical resistance of fluoroquinolones in Staphylococcus aureus. Antimicrob Agents Chemother 1991; 35: 2562-2567.
7. Yamaguchi K, Ohno A: Considerations on MRSA infections in relation to modern chemotherapy. Nippon Rinsho 1992; 50: 923-931.
8. Matsunaga T, Hasegawa M, Ryono K, et al: In vitro antimicrobial activity of new quinolones against clinical isolates of MRSA. Antibiot Chemother 1996; 12: 701-712